Eventide Asset Management Cut Loxo Oncology (LOXO) Position; 2 Analysts Covering Rite Aid (RAD)

November 14, 2017 - By Michael Collier

Eventide Asset Management Llc decreased Loxo Oncology Inc (LOXO) stake by 8.46% reported in 2017Q2 SEC filing. Eventide Asset Management Llc sold 49,000 shares as Loxo Oncology Inc (LOXO)’s stock rose 10.54%. The Eventide Asset Management Llc holds 530,000 shares with $42.50 million value, down from 579,000 last quarter. Loxo Oncology Inc now has $2.37 billion valuation. The stock declined 4.87% or $4.05 reaching $79.18 per share. About 2.28M shares traded or 579.31% up from the average. Loxo Oncology Inc (NASDAQ:LOXO) has risen 77.12% since November 14, 2016 and is uptrending. It has outperformed by 60.42% the S&P500.

Among 14 analysts covering Rite Aid (NYSE:RAD), 2 have Buy rating, 2 Sell and 10 Hold. Therefore 14% are positive. Rite Aid had 22 analyst reports since August 6, 2015 according to SRatingsIntel. The firm earned “Buy” rating on Friday, August 14 by Vetr. The firm earned “Neutral” rating on Thursday, October 29 by Goldman Sachs. The stock of Rite Aid Corporation (NYSE:RAD) earned “Buy” rating by Mizuho on Thursday, September 17. The stock of Rite Aid Corporation (NYSE:RAD) has “Underperform” rating given on Friday, June 30 by Evercore. The stock of Rite Aid Corporation (NYSE:RAD) earned “Neutral” rating by Guggenheim on Wednesday, April 26. The stock of Rite Aid Corporation (NYSE:RAD) earned “Buy” rating by Bank of America on Thursday, August 13. Bank of America reinitiated the stock with “Underperform” rating in Friday, June 30 report. Credit Suisse downgraded the shares of RAD in report on Thursday, October 29 to “Neutral” rating. The rating was maintained by Mizuho on Friday, October 6 with “Neutral”. The rating was downgraded by Mizuho to “Neutral” on Thursday, July 20. See Rite Aid Corporation (NYSE:RAD) latest ratings:

25/10/2017 Broker: RBC Capital Markets Rating: Hold New Target: $2.0 Maintain
06/10/2017 Broker: Mizuho Rating: Neutral Old Target: $2.95 New Target: $2.25 Maintain
29/09/2017 Broker: Loop Capital Rating: Hold Old Target: $2.5 New Target: $2 Maintain
19/09/2017 Broker: RBC Capital Markets Rating: Sector Perform New Target: $2.5 Initiates Coverage On
11/09/2017 Broker: Loop Capital Markets Rating: Hold New Target: $2.5 Initiate
20/07/2017 Broker: Mizuho Old Rating: Buy New Rating: Neutral Downgrade
30/06/2017 Broker: Bank of America Rating: Underperform New Target: $2.00 Reinitiate
30/06/2017 Broker: Evercore Rating: Underperform New Target: $2.50 Reinitiate

Investors sentiment increased to 3.83 in 2017 Q2. Its up 1.64, from 2.19 in 2017Q1. It increased, as 5 investors sold LOXO shares while 18 reduced holdings. 43 funds opened positions while 45 raised stakes. 57.37 million shares or 120.56% more from 26.01 million shares in 2017Q1 were reported. Victory Cap Management Incorporated holds 0.15% or 800,472 shares in its portfolio. Strs Ohio invested in 2,500 shares. Aisling Cap Limited Liability has invested 57.53% in Loxo Oncology Inc (NASDAQ:LOXO). Moreover, Invesco has 0% invested in Loxo Oncology Inc (NASDAQ:LOXO). 37,849 were reported by Nationwide Fund Advsr. Spark Inv Management Lc reported 0.1% of its portfolio in Loxo Oncology Inc (NASDAQ:LOXO). Citigroup Incorporated reported 8,349 shares. Atika Cap Limited Liability Co stated it has 42,000 shares or 1.18% of all its holdings. Moreover, Pnc Ser Gp has 0% invested in Loxo Oncology Inc (NASDAQ:LOXO) for 200 shares. Dekabank Deutsche Girozentrale stated it has 19,200 shares or 0.01% of all its holdings. Baker Bros Advsr LP holds 138,312 shares or 0.1% of its portfolio. Wellington Mgmt Grp Ltd Liability Partnership invested in 2.45 million shares or 0.05% of the stock. State Board Of Administration Of Florida Retirement Sys reported 8,360 shares. State Street stated it has 539,555 shares or 0% of all its holdings. Td Asset Mgmt holds 9,710 shares or 0% of its portfolio.

Eventide Asset Management Llc increased First Hawaiian Inc stake by 18,000 shares to 42,000 valued at $1.29M in 2017Q2. It also upped Spectra Energy Partners Lp (NYSE:SEP) stake by 14,500 shares and now owns 52,500 shares. Achillion Pharmaceuticals In (NASDAQ:ACHN) was raised too.

Analysts await Loxo Oncology Inc (NASDAQ:LOXO) to report earnings on March, 6. They expect $-1.29 EPS, down 0.78% or $0.01 from last year’s $-1.28 per share. After $-1.12 actual EPS reported by Loxo Oncology Inc for the previous quarter, Wall Street now forecasts 15.18% negative EPS growth.

Since May 22, 2017, it had 0 insider purchases, and 1 insider sale for $326,936 activity. $326,936 worth of stock was sold by Flaherty Keith T. on Monday, May 22.

Among 8 analysts covering Loxo Oncology Inc (NASDAQ:LOXO), 6 have Buy rating, 1 Sell and 1 Hold. Therefore 75% are positive. Loxo Oncology Inc had 25 analyst reports since July 29, 2015 according to SRatingsIntel. On Friday, October 20 the stock rating was maintained by Citigroup with “Buy”. BTIG Research maintained the shares of LOXO in report on Monday, June 5 with “Buy” rating. Stifel Nicolaus maintained it with “Buy” rating and $7100 target in Monday, June 5 report. The rating was initiated by Citigroup on Friday, January 15 with “Buy”. The firm has “Market Perform” rating given on Tuesday, August 29 by JMP Securities. Stifel Nicolaus maintained Loxo Oncology Inc (NASDAQ:LOXO) on Wednesday, September 27 with “Buy” rating. The stock of Loxo Oncology Inc (NASDAQ:LOXO) has “Buy” rating given on Thursday, November 2 by Stifel Nicolaus. Stifel Nicolaus maintained it with “Buy” rating and $37 target in Wednesday, November 11 report. The firm has “Buy” rating given on Tuesday, August 4 by Oppenheimer. Citigroup initiated it with “Buy” rating and $32 target in Monday, January 18 report.

Rite Aid Corporation is a retail drugstore chain. The company has market cap of $1.59 billion. The Company’s divisions include Retail Pharmacy and Pharmacy Services. It has a 18.25 P/E ratio. The Firm operates under The Rite Aid name.

About 14.92M shares traded. Rite Aid Corporation (NYSE:RAD) has declined 55.18% since November 14, 2016 and is downtrending. It has underperformed by 71.88% the S&P500.

Investors sentiment decreased to 0.78 in 2017 Q2. Its down 0.46, from 1.24 in 2017Q1. It fall, as 85 investors sold Rite Aid Corporation shares while 96 reduced holdings. 50 funds opened positions while 91 raised stakes. 539.25 million shares or 5.01% less from 567.71 million shares in 2017Q1 were reported. Voya Inv Mngmt Ltd Liability has 346,527 shares for 0% of their portfolio. Moreover, Rhumbline Advisers has 0.01% invested in Rite Aid Corporation (NYSE:RAD). Pentwater Capital Mgmt Ltd Partnership holds 0.05% or 2.05M shares. Cwm Ltd Liability Co holds 0% in Rite Aid Corporation (NYSE:RAD) or 1,400 shares. State Board Of Administration Of Florida Retirement System has invested 0.01% of its portfolio in Rite Aid Corporation (NYSE:RAD). Hbk Investments L P owns 1.14M shares. Point72 Asia (Hong Kong) accumulated 77,412 shares. Utd Svcs Automobile Association holds 0% of its portfolio in Rite Aid Corporation (NYSE:RAD) for 61,638 shares. Dimensional Fund Advisors Limited Partnership reported 2.77 million shares. Park Circle Co invested 0.99% of its portfolio in Rite Aid Corporation (NYSE:RAD). Yakira Cap owns 441,046 shares. D E Shaw & invested in 0% or 162,994 shares. Deutsche Bancorp Ag stated it has 0.02% of its portfolio in Rite Aid Corporation (NYSE:RAD). Boston Family Office holds 0.01% or 22,500 shares. Nomura Asset Mngmt accumulated 27,277 shares.

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.

By

Free Email Newsletter

Enter your email address below to get the latest news and analysts' ratings for your stocks with our FREE daily email newsletter:


Recent Market News

>